Medical Diagnostic Laboratories, L.L.C. v. Protagonist Therapeutics, Inc.

Filing 48

STIPULATION AND ORDER re 47 Continuing March 8, 2018 Further Case Management Conference filed by Medical Diagnostic Laboratories, L.L.C. Case Management Statement due by 3/29/2018. Further Case Management Conference set for 4/5/2018 10:30 AM in San Francisco, Courtroom 05, 17th Floor. Signed by Judge Edward M. Chen on 3/6/18. (bpf, COURT STAFF) (Filed on 3/6/2018)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Jeffrey D. Wexler (CA SBN 132256)
Christopher E. Stretch (CA SBN 166752)
PILLSBURY WINTHROP SHAW PITTMAN LLP
4 Embarcadero Center, Suite 2200
San Francisco, CA 94111-5998
Telephone: [phone]
Facsimile: 415-983-1200
[e-mail]
[e-mail]

Michelle S. Rhyu (212922)
Lauren J. Krickl (305379)
COOLEY LLP
3175 Hanover Street
Palo Alto, CA 94304-1130
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]

Arthur I. Neustadt (Permanent Member of NDCA)
Eric W. Schweibenz (admitted pro hac vice)
Tia D. Fenton (admitted pro hac vice)
Vincent K. Shier, Ph.D. (admitted pro hac vice)
OBLON, McCLELLAND, MAIER &
NEUSTADT, L.L.P.
1940 Duke Street
Alexandria, VA 22314
Telephone: [phone]
Facsimile: 703-413-2220
[e-mail]
[e-mail]
[e-mail]
[e-mail]

Jason A. Lief (NY 2717692) (admitted
pro hac vice)
COOLEY LLP
1114 Avenue of the Americas
New York, NY 10036
Telephone: [phone]
Facsimile: [phone]
[e-mail]

Attorneys for Plaintiff Medical Diagnostic
Laboratories, L.L.C.

Attorneys for Defendant Protagonist
Therapeutics, Inc.

17
18

UNITED STATES DISTRICT COURT

19

NORTHERN DISTRICT OF CALIFORNIA

20

Case No. 3:17-cv-05572

21
22
23

MEDICAL DIAGNOSTIC
LABORATORIES, L.L.C.,

24

Plaintiff,

25

STIPULATION AND [PROPOSED] ORDER
CONTINUING FURTHER CASE
MANAGEMENT CONFERENCE

v.

26
27

Date: March 8, 2018
Time: 10:30 a.m.
PROTAGONIST THERAPEUTICS, INC., Judge: Hon. Edward M. Chen
Location: Courtroom: 5
Defendant.

28
STIPULATION AND PROPOSED ORDER TO CONTINUE FURTHER CMC
Case No. 3:17-cv-05572
-14834-2073-2254.v1

1

This stipulation is entered into by and among Medical Diagnostic Laboratories, L.L.C.

2

(“MDL” or “Plaintiff”) and Protagonist Therapeutics, Inc. (“Protagonist” or “Defendant”)

3

(collectively the “Parties”), by and through their respective counsel.

4
5
6
7
8
9
10
11
12
13
14
15
16
17

WHEREAS, MDL filed its Complaint in this action against Protagonist on September 26,
2017;
WHEREAS, the Parties stipulated on October 31, 2017 to provide Protagonist an
additional 30 days to respond to MDL’s Complaint;
WHEREAS, Protagonist filed a motion to dismiss this case on December 1, 2017;
WHEREAS, at the January 19, 2018 hearing on Protagonist’s Motion to Dismiss, the
Court set a further case management conference for March 8, 2018 at 10:30 a.m.;
WHEREAS, the Court granted Protagonist’s Motion to Dismiss with leave to amend on
February 7, 2018 and set the deadline for MDL to amend its Complaint for March 9, 2018 (30
days after its Order);
WHEREAS, MDL has not made a final decision on whether it intends to file an amended
Complaint;
WHEREAS, the Parties agree that a continuance of the March 8, 2018 Further Case

18

Management conference will permit more efficient case management, will serve the interests of

19

judicial economy and will conserve Party and Court resources;

20
21

NOW, THEREFORE, pursuant to Civil Local Rule 6-2(a), the Parties hereby stipulate
and agree, through their respective counsel, as follows:

22

1. The March 8, 2018 Further Case Management Conference shall be taken off calendar

23

and rescheduled for April 5, 2018 at 10:30 a.m. or another date that is convenient for

24

the Court.

25
26

IT IS SO STIPULATED.

27
28
STIPULATION AND PROPOSED ORDER TO CONTINUE FURTHER CMC
Case No. 3:17-cv-05572
-24834-2073-2254.v1

1
2
3
4

Dated: March 6, 2018

5

PILLSBURY WINTHROP SHAW PITTMAN LLP
Jeffrey D. Wexler
Christopher E. Stretch
OBLON, McCLELLAND, MAIER &
NEUSTADT, L.L.P.
Arthur I. Neustadt (Permanent Member of NDCA)
Eric W. Schweibenz (admitted pro hac vice)
Tia D. Fenton (admitted pro hac vice)
Vincent K. Shier, Ph.D. (admitted pro hac vice)

6
7
8
9
10

/s/ Eric W. Schweibenz

11

Eric W. Schweibenz
Attorneys for Plaintiff Medical Diagnostic
Laboratories, L.L.C.

12
13

17

/s/ Michelle S. Rhyu

18

Michelle S. Rhyu
Attorneys for Defendant Protagonist Therapeutics, Inc.

19

PURSUANT TO STIPULATION, IT IS SO ORDERED.
March 6,
Dated: _____________ 2018

S DISTRICT
TE
C
TA

RT
U
O

___________________________________
The Hon. Edward M. Chen
ERED
United StatesORD Judge
S SO District
I

UNIT
ED

22

S

21
23
24

RT

26

dwar
Judge E

ER

H

27
28

en

d M. Ch

NO

25

IT

R NIA

20

FO

16

COOLEY LLP
Michelle S. Rhyu
Jason A. Lief
Lauren J. Krickl

LI

15

Dated: March 6, 2018

A

14

N

F
D IS T IC T O
R

C

STIPULATION AND PROPOSED ORDER TO CONTINUE FURTHER CMC
Case No. 3:17-cv-05572
-3-

4834-2073-2254.v1

1
2

ATTESTATION OF CONCURRENCE IN FILING
Pursuant to the Northern District of California’s Local Rule 5-1(i)(3), I attest that all

3

signatories listed, and on whose behalf the filing is submitted, concur in the filing’s content and

4

have authorized the filing.

5
6
7
8
9
10
11
12
13
14

Dated: March 6, 2018

PILLSBURY WINTHROP SHAW PITTMAN LLP
Jeffrey D. Wexler
Christopher E. Stretch
OBLON, McCLELLAND, MAIER &
NEUSTADT, L.L.P.
Arthur I. Neustadt (Permanent Member of NDCA)
Eric W. Schweibenz (admitted pro hac vice)
Tia D. Fenton (admitted pro hac vice)
Vincent K. Shier, Ph.D. (admitted pro hac vice)
/s/ Eric W. Schweibenz
Eric W. Schweibenz
Attorneys for Plaintiff Medical Diagnostic
Laboratories, L.L.C.

15
16
17
18
19
20
21
22
23
24
25
26
27
28
STIPULATION AND PROPOSED ORDER TO CONTINUE FURTHER CMC
Case No. 3:17-cv-05572
-44834-2073-2254.v1